Protection conferred by vaccine plus previous infection (hybrid immunity) with vaccines of three different platforms during the Omicron variant period in Brazil
View ORCID ProfileThiago Cerqueira-Silva, Vinicius de Araujo Oliveira, Enny S. Paixão, Pilar Tavares Veras Florentino, Gerson O. Penna, Neil Pearce, Guilherme L. Werneck, Maurício L. Barreto, Viviane S. Boaventura, Manoel Barral-Netto
doi: https://doi.org/10.1101/2022.04.12.22273752
Thiago Cerqueira-Silva
1LIB and LEITV Laboratories, Instituto Gonçalo Moniz, Fiocruz, Salvador, Bahia, Brazil
2Universidade Federal da Bahia, Salvador, Bahia, Brazil
MDVinicius de Araujo Oliveira
2Universidade Federal da Bahia, Salvador, Bahia, Brazil
4Center of Data and Knowledge Integration for Health (CIDACS), Instituto Gonçalo Moniz, Fiocruz, Salvador, Bahia, Brazil
MDEnny S. Paixão
3London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK
PhDPilar Tavares Veras Florentino
4Center of Data and Knowledge Integration for Health (CIDACS), Instituto Gonçalo Moniz, Fiocruz, Salvador, Bahia, Brazil
5Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil
PhDGerson O. Penna
6Núcleo de Medicina Tropical, Universidade de Brasília. Escola Fiocruz de Governo, Fiocruz, DF, Brazil
MDNeil Pearce
3London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK
PhDGuilherme L. Werneck
7Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil
8Universidade Federal do Rio de Janeiro, Rio de Janeiro,Brazil
MDMaurício L. Barreto
2Universidade Federal da Bahia, Salvador, Bahia, Brazil
4Center of Data and Knowledge Integration for Health (CIDACS), Instituto Gonçalo Moniz, Fiocruz, Salvador, Bahia, Brazil
MDViviane S. Boaventura
1LIB and LEITV Laboratories, Instituto Gonçalo Moniz, Fiocruz, Salvador, Bahia, Brazil
2Universidade Federal da Bahia, Salvador, Bahia, Brazil
MDManoel Barral-Netto
1LIB and LEITV Laboratories, Instituto Gonçalo Moniz, Fiocruz, Salvador, Bahia, Brazil
2Universidade Federal da Bahia, Salvador, Bahia, Brazil
MDArticle usage
Posted April 13, 2022.
Protection conferred by vaccine plus previous infection (hybrid immunity) with vaccines of three different platforms during the Omicron variant period in Brazil
Thiago Cerqueira-Silva, Vinicius de Araujo Oliveira, Enny S. Paixão, Pilar Tavares Veras Florentino, Gerson O. Penna, Neil Pearce, Guilherme L. Werneck, Maurício L. Barreto, Viviane S. Boaventura, Manoel Barral-Netto
medRxiv 2022.04.12.22273752; doi: https://doi.org/10.1101/2022.04.12.22273752
Protection conferred by vaccine plus previous infection (hybrid immunity) with vaccines of three different platforms during the Omicron variant period in Brazil
Thiago Cerqueira-Silva, Vinicius de Araujo Oliveira, Enny S. Paixão, Pilar Tavares Veras Florentino, Gerson O. Penna, Neil Pearce, Guilherme L. Werneck, Maurício L. Barreto, Viviane S. Boaventura, Manoel Barral-Netto
medRxiv 2022.04.12.22273752; doi: https://doi.org/10.1101/2022.04.12.22273752
Subject Area
Subject Areas
- Addiction Medicine (336)
- Allergy and Immunology (662)
- Anesthesia (177)
- Cardiovascular Medicine (2584)
- Dermatology (218)
- Emergency Medicine (390)
- Epidemiology (12115)
- Forensic Medicine (10)
- Gastroenterology (751)
- Genetic and Genomic Medicine (4014)
- Geriatric Medicine (377)
- Health Economics (670)
- Health Informatics (2592)
- Health Policy (994)
- Hematology (357)
- HIV/AIDS (828)
- Medical Education (397)
- Medical Ethics (107)
- Nephrology (425)
- Neurology (3784)
- Nursing (207)
- Nutrition (560)
- Oncology (1972)
- Ophthalmology (574)
- Orthopedics (233)
- Otolaryngology (301)
- Pain Medicine (248)
- Palliative Medicine (72)
- Pathology (469)
- Pediatrics (1094)
- Primary Care Research (442)
- Public and Global Health (6454)
- Radiology and Imaging (1371)
- Respiratory Medicine (866)
- Rheumatology (395)
- Sports Medicine (336)
- Surgery (434)
- Toxicology (51)
- Transplantation (185)
- Urology (165)